ABCL logo

AbCellera Biologics (ABCL) Revenue

Annual Revenue

$28.83 M
-$9.19 M-24.17%

December 31, 2024


Summary


Performance

ABCL Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABCLprofitabilitymetrics:

Quarterly Revenue

$5.05 M
-$1.46 M-22.39%

December 31, 2024


Summary


Performance

ABCL Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$28.83 M
-$4.13 M-12.53%

December 31, 2024


Summary


Performance

ABCL TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABCLprofitabilitymetrics:

ABCL Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-24.2%-22.4%-12.5%
3 y3 years-92.3%-22.4%-12.5%
5 y5 years+148.3%-22.4%-12.5%

ABCL Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-94.1%at low-98.4%at low-95.2%at low
5 y5-year-94.1%+148.3%-98.4%+57.7%-95.2%+800.3%
alltimeall time-94.1%+226.5%-98.4%+57.7%-95.2%+800.3%

AbCellera Biologics Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$28.83 M(-24.2%)
$5.05 M(-22.4%)
$28.83 M(-12.5%)
Sep 2024
-
$6.51 M(-11.1%)
$32.96 M(-0.3%)
Jun 2024
-
$7.32 M(-26.4%)
$33.05 M(-7.6%)
Mar 2024
-
$9.95 M(+8.4%)
$35.79 M(-5.9%)
Dec 2023
$38.02 M(-92.2%)
$9.18 M(+39.1%)
$38.03 M(-24.5%)
Sep 2023
-
$6.60 M(-34.4%)
$50.39 M(-65.3%)
Jun 2023
-
$10.06 M(-17.5%)
$145.18 M(-19.8%)
Mar 2023
-
$12.19 M(-43.4%)
$181.04 M(-62.7%)
Dec 2022
$485.42 M
$21.55 M(-78.7%)
$485.43 M(-19.5%)
Sep 2022
-
$101.38 M(+120.8%)
$603.21 M(+18.9%)
Jun 2022
-
$45.92 M(-85.5%)
$507.34 M(+3.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
$316.58 M(+127.2%)
$489.06 M(+30.3%)
Dec 2021
$375.20 M(+60.9%)
$139.33 M(+2429.6%)
$375.22 M(-15.5%)
Sep 2021
-
$5.51 M(-80.1%)
$443.80 M(-0.9%)
Jun 2021
-
$27.64 M(-86.4%)
$447.65 M(+3.8%)
Mar 2021
-
$202.74 M(-2.5%)
$431.24 M(+85.0%)
Dec 2020
$233.16 M(+1907.9%)
$207.91 M(+2120.8%)
$233.16 M(+719.5%)
Sep 2020
-
$9.36 M(-16.6%)
$28.45 M(+49.0%)
Jun 2020
-
$11.23 M(+141.1%)
$19.09 M(+142.9%)
Mar 2020
-
$4.66 M(+45.4%)
$7.86 M(+145.4%)
Dec 2019
$11.61 M(+31.5%)
$3.20 M
$3.20 M
Dec 2018
$8.83 M
-
-

FAQ

  • What is AbCellera Biologics annual revenue?
  • What is the all time high annual revenue for AbCellera Biologics?
  • What is AbCellera Biologics annual revenue year-on-year change?
  • What is AbCellera Biologics quarterly revenue?
  • What is the all time high quarterly revenue for AbCellera Biologics?
  • What is AbCellera Biologics quarterly revenue year-on-year change?
  • What is AbCellera Biologics TTM revenue?
  • What is the all time high TTM revenue for AbCellera Biologics?
  • What is AbCellera Biologics TTM revenue year-on-year change?

What is AbCellera Biologics annual revenue?

The current annual revenue of ABCL is $28.83 M

What is the all time high annual revenue for AbCellera Biologics?

AbCellera Biologics all-time high annual revenue is $485.42 M

What is AbCellera Biologics annual revenue year-on-year change?

Over the past year, ABCL annual revenue has changed by -$9.19 M (-24.17%)

What is AbCellera Biologics quarterly revenue?

The current quarterly revenue of ABCL is $5.05 M

What is the all time high quarterly revenue for AbCellera Biologics?

AbCellera Biologics all-time high quarterly revenue is $316.58 M

What is AbCellera Biologics quarterly revenue year-on-year change?

Over the past year, ABCL quarterly revenue has changed by -$1.46 M (-22.39%)

What is AbCellera Biologics TTM revenue?

The current TTM revenue of ABCL is $28.83 M

What is the all time high TTM revenue for AbCellera Biologics?

AbCellera Biologics all-time high TTM revenue is $603.21 M

What is AbCellera Biologics TTM revenue year-on-year change?

Over the past year, ABCL TTM revenue has changed by -$4.13 M (-12.53%)